We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The Concomitant Use of Melatonin and Molnupiravir in the Treatment of COVID-19: Mini Review.
- Authors
Haskologlu, Ismail Celil; Erdag, Emine; Sayiner, Serkan; Mercan, Merve; Chukwunyere, Ugochukwu; Abacioglu, Nurettin; Sehirli, Ahmet Ozer
- Abstract
With the ongoing pandemic declared by the World Health Organization, the number of hospitalizations and deaths caused by COVID-19 is increasing dramatically. As new variants of SARS-CoV-2 emerge, new combination therapies are needed to reduce the risk of COVID-19spreadduring this time of increased transmission risk. In this case, it is vitalto strengthen the immune system against highly inflammatory conditions such as the cytokine storm caused by COVID-19. This brief review highlights the benefits of taking melatonin and the new antiviral drug molnupiravir together in the treatment of COVID-19. Webelieve that this combination therapy against COVID-19 would be of great benefit and should be considered as an adjuvant therapy in the treatment of this disease.
- Subjects
WORLD Health Organization; COVID-19 treatment; MOLNUPIRAVIR; SARS-CoV-2; THERAPEUTICS; MELATONIN
- Publication
Bangladesh Journal of Medical Science, 2023, Vol 22, Issue 1, p32
- ISSN
2223-4721
- Publication type
Article
- DOI
10.3329/bjms.v22i1.61857